Siemens Healthineers Sees Faster Growth in Diagnostics Business

The video features an interview with Bernd Montag, CEO of Siemens Healthineers, discussing the company's profit goals, new diagnostic system Al Tallica, and their strong imaging business. Montag elaborates on the global production strategy, highlighting the flexibility between factories in China and Germany. He identifies emerging markets like Latin America, China, and India as key growth areas. The discussion also covers the potential impact of currency fluctuations and Brexit on the business, emphasizing the company's preparedness for logistical challenges.

What are the profit goals that Siemens Healthineers is raising?

What is the name of the new diagnostic system mentioned in the text?

How has Siemens Healthineers adjusted its production strategy in response to global demands?

Which markets are identified as having the biggest growth potential for Siemens Healthineers?

How does Siemens Healthineers plan to grow its therapies business?

What challenges does Siemens Healthineers face regarding emerging market currencies?

What preparations has Siemens Healthineers made in anticipation of a hard Brexit?